Propanc Biopharma plans Phase 1b trial for cancer drug PRP

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. IONS
4. ROIV
5. AAPL
6. ACN
7. AZN
8. ORCL
9. HOOD
10. QCOM

Go back to Propanc Biopharma plans Phase 1b trial for cancer drug PRP
(NASDAQ: PPCB) Delayed: 1.01 --0 (-0%)
Previous Close $1.01    52 Week High $ 
Open $1.02    52 Week Low $ 
Day High $1.04    P/E N/A 
Day Low $1.00    EPS $ 
Volume 101,234       

(NASDAQ: RVMD) Delayed: 210.42 +0.40 (0.19%)
Previous Close $210.02    52 Week High $ 
Open $208.07    52 Week Low $ 
Day High $213.00    P/E N/A 
Day Low $206.47    EPS $ 
Volume 543,361